[{"begin": 0, "end": 92, "text": "Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H.", "tokenized_text": "Lucas AL , Frado LE , Hwang C , Kumar S , Khanna LG , Levinson EJ , Chabot JA , Chung WK , Frucht H .", "type": "authors", "id": 0}, {"begin": 93, "end": 231, "text": "BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts", "tokenized_text": "BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high - risk pancreatic cancer screening and pancreatic cancer cohorts", "type": "title", "id": 1}, {"begin": 233, "end": 239, "text": "Cancer", "tokenized_text": "Cancer", "type": "venue", "id": 2}, {"begin": 241, "end": 245, "text": "2014", "tokenized_text": "2014", "type": "year", "id": 3}, {"begin": 0, "end": 92, "text": "Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H.", "tokenized_text": "Lucas AL , Frado LE , Hwang C , Kumar S , Khanna LG , Levinson EJ , Chabot JA , Chung WK , Frucht H .", "type": "authors", "id": 4}, {"begin": 93, "end": 231, "text": "BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts", "tokenized_text": "BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high - risk pancreatic cancer screening and pancreatic cancer cohorts", "type": "title", "id": 5}, {"begin": 233, "end": 239, "text": "Cancer", "tokenized_text": "Cancer", "type": "venue", "id": 6}, {"begin": 241, "end": 245, "text": "2014", "tokenized_text": "2014", "type": "year", "id": 7}]